Logo

The Nostradamus of Sequencing

Dec 17, 2009

Forbes' Matthew Herper predicts that the $1,000 genome will become a reality in 2010, "ushering in a new era of genetic medicine." Herper says that direct-to-consumer personalized genomics companies aren't "ready for prime time." Instead, he says that the traditional doctor-insurer-patient model will be more fruitful. The companies on his watch list include Illumina, Complete Genomics, Pacific Biosciences, and Ion Torrent.

Breaking News
The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.